High Vista Strategies LLC Beam Therapeutics Inc. Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $334,076 - $590,322
-8,396 Reduced 40.02%
12,584 $600,000
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $294,957 - $615,992
9,878 Added 88.97%
20,980 $812,000
Q1 2022

May 16, 2022
SELL
$53.73 - $82.16 $130,886 - $200,141
-2,436 Reduced 17.99%
11,102 $636,000
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $140,393 - $204,459
2,064 Added 17.99%
13,538 $1.08 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $968,061 - $1.53 Million
11,474 New
11,474 $998,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email